Dhanlaxmi Crop Science Ltd.

As of March 31, 2026, Dhanlaxmi Crop Science Ltd. carries a market capitalization of 369.83M, placing it among publicly traded companies globally. Its enterprise value stands at 461.62M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Dhanlaxmi Crop Science Ltd. has 16.33M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.97, and the price-to-book ratio stands at 0.81.

As of March 31, 2026, Dhanlaxmi Crop Science Ltd. trades at an EV/EBITDA multiple of 44.42 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.21 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 91.16 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 461.62M versus a market cap of 369.83M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Dhanlaxmi Crop Science Ltd. maintains a current ratio of 3.78, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 23.28, indicating elevated leverage, while an interest coverage ratio of 1.24 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Dhanlaxmi Crop Science Ltd. posted a negative return on equity (ROE) of -1.08, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -0.67, reflecting losses generated across the asset base. The company generates approximately 7.33M in revenue per employee across its workforce of 52.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.68 indicates how many times Dhanlaxmi Crop Science Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Dhanlaxmi Crop Science Ltd. recorded 331,000.00 in income tax expense. The company reported a pretax loss of -4.58M and -4.92M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Dhanlaxmi Crop Science Ltd.'s stock has declined approximately 34.06% over the past 52 weeks. The 50-day moving average sits at 25.43, while the 200-day moving average is 28.13.

Over the twelve months ended March 31, 2026, Dhanlaxmi Crop Science Ltd. generated 381.28M in revenue and converted that into -4.92M in net income, yielding earnings per share of -0.30. EBITDA reached 10.39M, while operating income came in at 5.06M.

As of March 31, 2026, Dhanlaxmi Crop Science Ltd. holds 14.03M in cash and equivalents against 105.82M in total debt, resulting in a net debt position of 91.79M. Total book value stands at 454.47M, with working capital of 436.01M providing operational flexibility.

Dhanlaxmi Crop Science Ltd. produced -138.20M in operating cash flow over the twelve months ended March 31, 2026. After subtracting -12.29M in capital expenditures, free cash flow totaled -150.49M - equivalent to -9.22 per share.

Over the twelve months ended March 31, 2026, Dhanlaxmi Crop Science Ltd. posted a gross margin of 26.03, reflecting its pricing power and cost economics. The operating margin of 1.33 and net profit margin of -1.29 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -40.69: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -6.96, meaning Dhanlaxmi Crop Science Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of March 31, 2026, Dhanlaxmi Crop Science Ltd. has an Altman Z-Score of 2.94, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.